文献速递创伤骨科骨质疏松与代谢性骨病

使用抗精神病药增加骨折风险:一项系统综述与Meta分析

Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
PubMed 文献 · Osteoporos Int · 2017-01-12

该系统综述与Meta分析纳入19项观察性研究(n=544,811名参与者,80,835例骨折),评估抗精神病药使用与骨折的关联。与非使用者相比,第一代抗精神病药(FGA)使用者髋部骨折风险显著升高(OR 1.67,95%CI 1.45-1.93),第二代抗精神病药(SGA)使用者风险有所减弱但仍显著(OR 1.33,95%CI 1.11-1.58)。作者结论为FGA使用者髋部骨折风险高于SGA使用者,两类药物均与骨折风险增加相关,尤其在老年人群中。

要点

  • 与非使用者相比,FGA使用者髋部骨折风险显著升高(OR 1.67,95%CI 1.45-1.93)。
  • 与非使用者相比,SGA使用者髋部骨折风险有所减弱但仍显著(OR 1.33,95%CI 1.11-1.58)。
  • FGA使用者髋部骨折风险高于SGA使用者,两类药物均与骨折风险增加相关,尤其在老年人群中。

核心结论

  • FGA使用者髋部骨折风险高于SGA使用者。
  • FGA和SGA均与骨折风险增加相关,尤其在老年人群中。
  • 作者认为,老年患者超说明书使用抗精神病药的获益应与任何骨折风险相权衡。

研究设计与样本

  • 通过PubMed和EMBASE数据库检索报告抗精神病药使用与骨折关联定量估计的观察性研究。
  • 纳入19项观察性研究,共544,811名参与者,80,835例骨折。
  • 采用随机效应Meta分析得出汇总风险。

主要发现

  • 与非使用者相比,FGA使用者髋部骨折风险显著升高(OR 1.67,95%CI 1.45-1.93)。
  • 与非使用者相比,SGA使用者髋部骨折风险有所减弱但仍显著(OR 1.33,95%CI 1.11-1.58)。
  • 不同类别抗精神病药使用者的骨折风险存在异质性,OR范围为1.24至2.01。
  • 氯丙嗪与最高骨折风险相关(OR 2.01,95%CI 1.43-2.83)。
  • 利培酮与最低骨折风险相关(OR 1.24,95%CI 0.95-1.83)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Our systematic review and meta-analysis of observational studies indicated that the use of antipsychotics was associated with a nearly 1.5-fold increase in the risk of fracture. First-generation antipsychotics (FGAs) appeared to carry a higher risk of fracture than second-generation antipsychotics (SGAs). INTRODUCTION: The risk of fractures associated with the use of antipsychotic medications has inconsistent evidence between different drug classes. A systematic review and meta-analysis was conducted to evaluate whether there is an association between the use of antipsychotic drugs and fractures. METHODS: Searches were conducted through the PubMed and EMBASE databases to identify observational studies that had reported a quantitative estimate of the association between use of antipsychotics and fractures. The summary risk was derived from random effects meta-analysis. RESULTS: The search yielded 19 observational studies (n = 544,811 participants) with 80,835 fracture cases. Compared with nonuse, use of FGAs was associated with a significantly higher risk for hip fractures (OR 1.67, 95% CI, 1.45-1.93), and use of second generation antipsychotics (SGAs) was associated with an attenuated but still significant risk for hip fractures (OR 1.33, 95% CI, 1.11-1.58). The risk of fractures associated with individual classes of antipsychotic users was heterogeneous, and odds ratios ranged from 1.24 to 2.01. Chlorpromazine was associated with the highest risk (OR 2.01, 95% CI 1.43-2.83), while Risperidone was associated with the lowest risk of fracture (OR 1.24, 95% CI 0.95-1.83). CONCLUSIONS: FGA users were at a higher risk of hip fracture than SGA users. Both FGAs and SGAs were associated with an increased risk of fractures, especially among the older population. Therefore, the benefit of the off-label use of antipsychotics in elderly patients should be weighed against any risks for fracture.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Lee SH, Hsu WT, Lai CC, et al. Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis. Osteoporos Int. 2017. PMID: 28083669. doi:10.1007/s00198-016-3881-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。